Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Minority Interest (2016 - 2025)

Fortress Biotech (FBIO) has 11 years of Minority Interest data on record, last reported at $9.3 million in Q3 2025.

  • For Q3 2025, Minority Interest rose 127.5% year-over-year to $9.3 million; the TTM value through Sep 2025 reached $9.3 million, up 127.5%, while the annual FY2024 figure was -$24.4 million, 16.34% down from the prior year.
  • Minority Interest reached $9.3 million in Q3 2025 per FBIO's latest filing, up from -$6.5 million in the prior quarter.
  • Across five years, Minority Interest topped out at $140.0 million in Q2 2021 and bottomed at -$34.5 million in Q2 2023.
  • Average Minority Interest over 5 years is $27.4 million, with a median of $8.3 million recorded in 2022.
  • Peak YoY movement for Minority Interest: soared 263.46% in 2021, then crashed 352.37% in 2023.
  • A 5-year view of Minority Interest shows it stood at $117.2 million in 2021, then plummeted by 92.91% to $8.3 million in 2022, then plummeted by 352.37% to -$21.0 million in 2023, then dropped by 16.34% to -$24.4 million in 2024, then skyrocketed by 138.24% to $9.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Minority Interest were $9.3 million in Q3 2025, -$6.5 million in Q2 2025, and $10.2 million in Q1 2025.